A Study of rTMS Personalized Precision Treatment of Post-stroke Depression

Status Recruiting

Clinical Trial Summary

This is a multicenter, randomized trial aims to reveal the efficacy and safety of Repetitive transcranial magnetic stimulation (rTMS) individualized therapy based on the 'emotional loop destabilization' mechanism of PSD .One hundred and twenty participants will be recruited from three centers and randomized with a 1:1 ratio to receive "Personalized" rTMS treatment or traditional rTMS treatment in addition to routine antidepressant treatments.The data of neuropsychological tests and MRI will be collected at 0, 2，4 and 8 weeks after the commencement of the treatment.

Clinical Trial Description

This is a multicenter, randomized trial aims to reveal the efficacy and safety of rTMS individualized therapy based on the 'emotional loop destabilization' mechanism of PSD .One hundred and twenty participants will be recruited from three centers and randomized with a 1:1 ratio to receive "Personalized" rTMS treatment or traditional rTMS treatment in addition to routine antidepressant treatments.

Based on inclusion and exclusion criteria, after stroke depression (post-stroke depression, PSD) cases were collected and randomized into two groups: "individualized" rTMS+ drug treatment group and traditional rTMS plus traditional drug treatment group. The main indicators were the effective rate of treatment.Based on inclusion and exclusion criteria, after stroke depression (post-stroke depression, PSD) cases were collected and randomized into two groups: "individualized" rTMS+ drug treatment group and traditional rTMS plus traditional drug treatment group. The main indicators were the effective rate of treatment. The primary outcome is the measurement of 24-item Hamilton Depression Rating Scale (HAMD-24) scores, the secondary outcomes include National Institutes of Health Stroke Scale (NIHSS), Activities of Daily Living Scale (ADLs),self-rating anxiety scale(SAS). The record of the adverse reactions and sequelae during treatment and follow-up, with a view to providing a better clinical method for the treatment of PSD. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03256305
Study type	Interventional
Source	Zhujiang Hospital
Contact	Wen Wu, M.D
Phone	+86-020-62783189
Email	wuwen66@163.com
Status	Recruiting
Phase	N/A
Start date	December 2016
Completion date	October 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05612659` - Developing an EEG Probe for Studying and Modulating Cognitive Control	N/A
Active, not recruiting	`NCT06451965` - SCED - Wisdom Enhancement for Post-Stroke Depression	N/A
Completed	`NCT04093843` - TMS for Post Stroke Depression	N/A
Recruiting	`NCT05516680` - Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD	N/A
Recruiting	`NCT04876066` - Use of Transmucosal Ketamine in Post Stroke Depression	Phase 1
Recruiting	`NCT03159351` - The Antidepressant Effects of rTMS After Ischemic Stroke	N/A
Recruiting	`NCT03864484` - iPad Application-based Intervention for Post-stroke Depression	N/A
Recruiting	`NCT05310175` - Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression	N/A
Completed	`NCT03639259` - Emotional and Cognitive Determinants of Post-stroke Fatigue
Completed	`NCT02472613` - Acupuncture for Ischemic Post-stroke Depression	N/A
Completed	`NCT04008719` - ATtention Test and Executive Functions After STroke to Predict Depression.	N/A
Recruiting	`NCT05241782` - The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients	N/A
Withdrawn	`NCT03761303` - rTMS as an add-on Therapy in Patients With Post-stroke Depression	N/A
Completed	`NCT04318951` - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia	N/A
Completed	`NCT04560413` - Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients
Recruiting	`NCT05187975` - Integrated Rehabilitation in Treating Post-stroke Depression	N/A
Completed	`NCT06157333` - Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression	N/A
Completed	`NCT03829397` - To Investigate the Correlation of Stroke Patients and Demoralized
Recruiting	`NCT03789994` - Affective Touching on Poststroke Depression	N/A
Completed	`NCT05932550` - Safety of Maraviroc for Post-stroke Depression	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.